UPDATE 7:29 PM EST: Maria will be suspended from tennis following her failed drug test.
After her press conference on Monday, the International Tennis Federation released a statement regarding the player's punishment.
Following regulations by its anti-doping program, the ITF announced Maria will be "provisionally suspended" starting on March 12, meaning she won't be able to participate in the Miami Open on March 22.
The announcement didn't release a specific length of time for the blonde's suspension, just that it will be effective "pending determination of the case."
You can read the full press release here.
Could this be the end of Maria Sharapova's career?!
On Monday, the tennis pro announced she had recently failed a drug test during this year's Australian Open, after coming in fifth in the tournament's Women's Singles competition.
The 28-year-old said in a press conference:
"I wanted to let you know that a few days ago I received a letter from the ITF that I had failed a drug test at the Australian Open. I failed the test and take full responsibility for it."
The blonde beauty explained that for ten years, a doctor has been prescribing her the drug Meldonium — which is not FDA-approved — for several health issues she began having back in 2006.
The sports star confessed that she had only known it by its medicinal brand name, Mildronat, rather than its scientific name, until she received the letter.
The athlete did admit that she received a letter in December of 2015 with all the changes to the World Anti-Doping Agency's prohibited substances, but did not look at the list of items that had been added for 2016.
The Russia native told the crowd: